BIO-RAD LABORATORIES, INC. — Director's Dealing 2021

Feb 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-02-19

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-19	Bio-Rad A Common Stock	M	400	$159.32	Acquired	2143.1070	Direct
2021-02-19	Bio-Rad A Common Stock	S	400	$640.94	Disposed	1743.1070	Direct
2021-02-19	Bio-Rad A Common Stock	S	327	$640.92	Disposed	1416.1070	Direct
2021-02-19	Bio-Rad A Common Stock	S	196.1070	$640.17	Disposed	1220.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-19	Non-Qualified Stock Option (right to buy)	$159.32	M	400	Disposed	2026-09-07	Bio-Rad A Common Stock (400)	Direct

Footnotes

F1: Includes 19.6358 and 0.6743 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2020 and 12/31/2020, respectively.

F2: The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.